BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 27552964)

  • 1. Chromosomal abnormalities in hepatic cysts point to novel polycystic liver disease genes.
    Wills ES; Cnossen WR; Veltman JA; Woestenenk R; Steehouwer M; Salomon J; Te Morsche RH; Huch M; Hehir-Kwa JY; Banning MJ; Pfundt R; Roepman R; Hoischen A; Drenth JP
    Eur J Hum Genet; 2016 Dec; 24(12):1707-1714. PubMed ID: 27552964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary, somatic mutations might promote cyst formation in patients with autosomal dominant polycystic liver disease.
    Janssen MJ; Waanders E; Te Morsche RH; Xing R; Dijkman HB; Woudenberg J; Drenth JP
    Gastroenterology; 2011 Dec; 141(6):2056-2063.e2. PubMed ID: 21856269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe Polycystic Liver Disease Is Not Caused by Large Deletions of the PRKCSH Gene.
    Cnossen WR; Maurits JS; Salomon J; Te Morsche RH; Waanders E; Drenth JP
    J Clin Lab Anal; 2016 Sep; 30(5):431-6. PubMed ID: 26365003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of PKD1 and PKD2 Somatic Variants in Autosomal Dominant Polycystic Kidney Cyst Epithelial Cells by Whole-Genome Sequencing.
    Zhang Z; Bai H; Blumenfeld J; Ramnauth AB; Barash I; Prince M; Tan AY; Michaeel A; Liu G; Chicos I; Rennert L; Giannakopoulos S; Larbi K; Hughes S; Salvatore SP; Robinson BD; Kapur S; Rennert H
    J Am Soc Nephrol; 2021 Dec; 32(12):3114-3129. PubMed ID: 34716216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic second-hit mutations leads to polycystic liver diseases.
    Banales JM; Munoz-Garrido P; Bujanda L
    World J Gastroenterol; 2013 Jan; 19(1):141-3. PubMed ID: 23326178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver cyst gene knockout in cholangiocytes inhibits cilium formation and Wnt signaling.
    Wills ES; Te Morsche RHM; van Reeuwijk J; Horn N; Geomini I; van de Laarschot LFM; Mans DA; Ueffing M; Boldt K; Drenth JPH; Roepman R
    Hum Mol Genet; 2017 Nov; 26(21):4190-4202. PubMed ID: 28973524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity in renal and hepatic epithelial cystic cells from ADPKD1 patients.
    Badenas C; Torra R; Pérez-Oller L; Mallolas J; Talbot-Wright R; Torregrosa V; Darnell A
    Eur J Hum Genet; 2000 Jul; 8(7):487-92. PubMed ID: 10909847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases.
    Cornec-Le Gall E; Torres VE; Harris PC
    J Am Soc Nephrol; 2018 Jan; 29(1):13-23. PubMed ID: 29038287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics and mechanisms of hepatic cystogenesis.
    van de Laarschot LFM; Drenth JPH
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1491-1497. PubMed ID: 28782656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease.
    Li A; Davila S; Furu L; Qian Q; Tian X; Kamath PS; King BF; Torres VE; Somlo S
    Am J Hum Genet; 2003 Mar; 72(3):691-703. PubMed ID: 12529853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity is present in SEC63 germline carriers with polycystic liver disease.
    Janssen MJ; Salomon J; Te Morsche RH; Drenth JP
    PLoS One; 2012; 7(11):e50324. PubMed ID: 23209713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex, Genotype, and Liver Volume Progression as Risk of Hospitalization Determinants in Autosomal Dominant Polycystic Liver Disease.
    Schönauer R; Sierks D; Boerrigter M; Jawaid T; Caroff L; Audrezet MP; Friedrich A; Shaw M; Degenhardt J; Forberger M; de Fallois J; Bläker H; Bergmann C; Gödiker J; Schindler P; Schlevogt B; Müller RU; Berg T; Patterson I; Griffiths WJ; Sayer JA; ; Popp B; Torres VE; Hogan MC; Somlo S; Watnick TJ; Nevens F; Besse W; Cornec-Le Gall E; Harris PC; Drenth JPH; Halbritter J
    Gastroenterology; 2024 May; 166(5):902-914. PubMed ID: 38101549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of the polycystic kidney disease (PKD1) region of chromosome 16p13 in renal cyst cells supports a loss-of-function model for cyst pathogenesis.
    Brasier JL; Henske EP
    J Clin Invest; 1997 Jan; 99(2):194-9. PubMed ID: 9005987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterozygosity of ALG9 in Association with Autosomal Dominant Polycystic Liver Disease.
    Boerrigter MM; Duijzer R; Te Morsche RHM; Drenth JPH
    Genes (Basel); 2023 Sep; 14(9):. PubMed ID: 37761895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in GANAB, Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease.
    Porath B; Gainullin VG; Cornec-Le Gall E; Dillinger EK; Heyer CM; Hopp K; Edwards ME; Madsen CD; Mauritz SR; Banks CJ; Baheti S; Reddy B; Herrero JI; Bañales JM; Hogan MC; Tasic V; Watnick TJ; Chapman AB; Vigneau C; Lavainne F; Audrézet MP; Ferec C; Le Meur Y; Torres VE; ; ; Harris PC
    Am J Hum Genet; 2016 Jun; 98(6):1193-1207. PubMed ID: 27259053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing.
    Lanktree MB; Haghighi A; Guiard E; Iliuta IA; Song X; Harris PC; Paterson AD; Pei Y
    J Am Soc Nephrol; 2018 Oct; 29(10):2593-2600. PubMed ID: 30135240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A genetic interaction network of five genes for human polycystic kidney and liver diseases defines polycystin-1 as the central determinant of cyst formation.
    Fedeles SV; Tian X; Gallagher AR; Mitobe M; Nishio S; Lee SH; Cai Y; Geng L; Crews CM; Somlo S
    Nat Genet; 2011 Jun; 43(7):639-47. PubMed ID: 21685914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolated polycystic liver disease genes define effectors of polycystin-1 function.
    Besse W; Dong K; Choi J; Punia S; Fedeles SV; Choi M; Gallagher AR; Huang EB; Gulati A; Knight J; Mane S; Tahvanainen E; Tahvanainen P; Sanna-Cherchi S; Lifton RP; Watnick T; Pei YP; Torres VE; Somlo S
    J Clin Invest; 2017 May; 127(5):1772-1785. PubMed ID: 28375157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The zebrafish as a model to study polycystic liver disease.
    Tietz Bogert PS; Huang BQ; Gradilone SA; Masyuk TV; Moulder GL; Ekker SC; Larusso NF
    Zebrafish; 2013 Jun; 10(2):211-7. PubMed ID: 23668934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive mutational analysis of PRKCSH and SEC63 broadens the spectrum of polycystic liver disease.
    Waanders E; te Morsche RH; de Man RA; Jansen JB; Drenth JP
    Hum Mutat; 2006 Aug; 27(8):830. PubMed ID: 16835903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.